ID   Panc 02.08
AC   CVCL_E277
AS   CVCL_U877
SY   Panc 2.08; PANC 2.8; Panc2.8; Panc2_8; Pa104C
DR   Cosmic; 949523
DR   Cosmic; 1509880
DR   Wikidata; Q54937514
RX   PubMed=18000365;
RX   PubMed=22753594;
RX   PubMed=24810906;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=18000365; DOI=10.1159/000108295;
RA   Griffin C.A., Morsberger L.A., Hawkins A.L., Haddadin M.H., Patel A.S.,
RA   Ried T., Schrock E., Perlman E.J., Jaffee E.M.;
RT   "Molecular cytogenetic characterization of pancreas cancer cell lines
RT   reveals high complexity chromosomal alterations.";
RL   Cytogenet. Genome Res. 118:148-156(2007).
//
RX   PubMed=22753594; DOI=10.1158/1078-0432.CCR-12-0827; PMCID=PMC3513499;
RA   Cui Y.-F., Brosnan-Cashman J.A., Blackford A.L., Sur S., Hruban R.H.,
RA   Kinzler K.W., Vogelstein B., Maitra A., Diaz L.A. Jr.,
RA   Iacobuzio-Donahue C.A., Eshleman J.R.;
RT   "Genetically defined subsets of human pancreatic cancer show unique in
RT   vitro chemosensitivity.";
RL   Clin. Cancer Res. 18:6519-6530(2012).
//
RX   PubMed=24810906; DOI=10.18632/oncotarget.1842; PMCID=PMC4058028;
RA   Vincent A., Hong S.-M., Hu C.-X., Omura N., Young A., Kim H., Yu J.,
RA   Knight S., Ayars M., Griffith M., Van Seuningen I., Maitra A.,
RA   Goggins M.G.;
RT   "Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes
RT   tumor growth.";
RL   Oncotarget 5:2575-2587(2014).
//